Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-24 @ 10:02 PM
NCT ID:
NCT00730132
Eligibility Criteria:
Inclusion Criteria:
* Male and Female, from 18 to 75 years old;
* Established diagnosis of CHD;
* Previous (at least, within 1 month before inclusion in the present study) treatment with statin;
* Levels of plasma TC and LDL-C above the recommended target values
(TC\> 4.5 mmol\\L; LDL-C\> 2.5 mmol/L);
* The written informed consent signed prior to the start of participation in the study.
Exclusion Criteria:
* Contraindications for statin and ezetimibe (Ezetrol) administration in accordance with local Russian Federation medical instructions.
* Patients refused to participate in the study and/or did not sign informed consent form.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00730132
Study Brief:
Protocol Section:
NCT00730132